RECIST and Choi criteria for response assessment (RA) in patients with inoperable and metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate. Cambridge GIST study group experience
暂无分享,去创建一个
H. Earl | R. Hardwick | V. Save | H. Hatcher | N. Cook | S. Fawcett | C. Jephcott | V. Bulusu | N. Carroll | Penny Moyle